Citius Pharmaceuticals reports 2018 executive compensation

CEO Myron Holubiak receives $681.3K

Citius Pharmaceuticals reported fiscal year 2018 executive compensation information on December 20, 2018.

In 2018, three executives at Citius Pharmaceuticals received on average a compensation package of $512,879, a 6% increase compared to previous year.

Average pay of disclosed executives at Citius Pharmaceuticals

Myron Holubiak, Chief Executive Officer, received $681,322 in total, which decreased by 2% compared to 2017. 66.05% of Holubiak's compensation, or $450,000, was in salary. Holubiak also received $186,750 in non-equity incentive plan and $44,572 in option awards.

Jaime Bartushak, Chief Financial Officer, received a compensation package of $458,992, which increased by 1% compared to previous year. 54.47% of the compensation package, or $250,000, was in salary.

Leonard Mazur, Chairman, earned $398,322 in 2018, a 30% increase compared to previous year.

Citius Pharmaceuticals' fiscal year ends on September 30.